Guidelines - Epid
Guidelines on administration of Influenza A (H1N1) 2009 vaccine 1. INTRODUCTION: This vaccine is a monovalent, unadjuvented inactivated, split‐virus vaccine, produced by the CSL
Download Guidelines - Epid
Information
Domain:
Source:
Link to this page:
Documents from same domain
COMPREHENSIVE MULTI-YEAR PLAN FOR …
www.epid.gov.lkMinistry of Health Government of the Democratic Socialist Republic of Sri Lanka COMPREHENSIVE MULTI-YEAR PLAN FOR IMMUNIZATION 2012 - …
Ministry of Health - Sri Lanka - Epid
www.epid.gov.lkMinistry of Health - Sri Lanka National Guidelines Guidelineson Management of Dengue Fever & Dengue Haemorrhagic Fever In Adults In Collaboration with the
Related documents
LIST OF LICENSED HUMAN VACCINE MANUFACTURING …
www.cdsco.nic.inLIST OF LICENSED HUMAN VACCINE MANUFACTURING FACILITIES IN INDIA List of Vaccine indigenous manufacturers in the private sector with address of
Guillain-Barré Syndrome and Influenza Vaccine
www.who.intConclusions (1) • A/NJ/76 (H1N1) influenza vaccine associated with increased risk of GBS in adults 6 - 8 weeks following vaccine in US civilians • Reasons unknown • No clear biological explanation • Data on risk of GBS following other swine-antigen containing vaccines too limited to allow for conclusions
OBSERVED RATE OF VACCINE REACTIONS Global Vaccine …
www.who.intI Global Vaccine Safety, Immunization, Vaccines and Biologicals 20, avenue Appia, Ch-1211 Geneva 27 The Vaccines In general, seasonal influenza vaccines are trivalent, containing a mixture of influenza A and B strains thought most likely to circulate